Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-002478
Filing Date
2025-05-19
Accepted
2025-05-19 16:10:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10835
2 JOINT FILING AGREEMENT p25-1253exhibit99_1.htm EX-99.1 4862
  Complete submission text file 0000902664-25-002478.txt   17504
Mailing Address 2 MANHATTANVILLE ROAD SUITE 203 PURCHASE NY 10577
Business Address 2 MANHATTANVILLE ROAD SUITE 203 PURCHASE NY 10577 2036352002
Teladoc Health, Inc. (Subject) CIK: 0001477449 (see all company filings)

EIN.: 043705970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89259 | Film No.: 25963999
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G